- $1.36bn
- $1.36bn
- $358.71m
- 95
- 77
- 76
- 97
Annual balance sheet for Innoviva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 246 | 202 | 291 | 194 | 412 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 93.9 | 111 | 64.1 | 84.1 | 86.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 342 | 314 | 444 | 344 | 554 |
Net Property, Plant And Equipment | 0.028 | 0.012 | 3.44 | 3.02 | 2.97 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,000 | 926 | 1,231 | 1,244 | 1,301 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.11 | 5.81 | 135 | 38.1 | 236 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 460 | 512 | 666 | 569 | 610 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 540 | 415 | 566 | 675 | 691 |
Total Liabilities & Shareholders' Equity | 1,000 | 926 | 1,231 | 1,244 | 1,301 |
Total Common Shares Outstanding |